Global Anti-Ageing Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

アンチエイジング薬の世界市場:ホルモン療法、抗酸化剤、酵素、幹細胞、その他

◆タイトル:Global Anti-Ageing Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21AR00941
◆調査・発行会社:Global Info Research
◆発行日:2021年4月
◆ページ数:100
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医療・医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥382,800見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥574,200見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥765,600見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Info Researchの日本における正規販売代理店です。

【レポートの概要】

GlobalInfoResearch社の本調査レポートでは、アンチエイジング薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。アンチエイジング薬の種類別市場規模(ホルモン療法、抗酸化剤、酵素、幹細胞、その他)、用途別市場規模(肌、髪、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Nu Skin、BIOTIME、Elysium Health、La Roche-Posay、DermaFix
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ホルモン療法、抗酸化剤、酵素、幹細胞、その他
・用途別分析2016年-2026年:肌、髪、その他
・アンチエイジング薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・アンチエイジング薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・アンチエイジング薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・アンチエイジング薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・アンチエイジング薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Anti-Ageing Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Anti-Ageing Drugs size is estimated to be xx million in 2020 from USD 80490 million in 2019, with a change of XX% between 2019 and 2020. The global Anti-Ageing Drugs market size is expected to grow at a CAGR of 7.2% for the next five years.

Market segmentation
Anti-Ageing Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others

Market segment by Application can be divided into
Skin
Hair
Others

The key market players for global Anti-Ageing Drugs market are listed below:
Nu Skin
BIOTIME
Elysium Health
La Roche-Posay
DermaFix

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Anti-Ageing Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Ageing Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Hormonal Therapy
1.2.3 Antioxidants
1.2.4 Enzymes
1.2.5 Stem Cells
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Ageing Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Skin
1.3.3 Hair
1.3.4 Others
1.4 Global Anti-Ageing Drugs Market Size & Forecast
1.4.1 Global Anti-Ageing Drugs Sales in Value (2016-2026))
1.4.2 Global Anti-Ageing Drugs Sales in Volume (2016-2026)
1.4.3 Global Anti-Ageing Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Anti-Ageing Drugs Production Capacity Analysis
1.5.1 Global Anti-Ageing Drugs Total Production Capacity (2016-2026)
1.5.2 Global Anti-Ageing Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Ageing Drugs Market Drivers
1.6.2 Anti-Ageing Drugs Market Restraints
1.6.3 Anti-Ageing Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Nu Skin
2.1.1 Nu Skin Details
2.1.2 Nu Skin Major Business
2.1.3 Nu Skin Anti-Ageing Drugs Product and Services
2.1.4 Nu Skin Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 BIOTIME
2.2.1 BIOTIME Details
2.2.2 BIOTIME Major Business
2.2.3 BIOTIME Anti-Ageing Drugs Product and Services
2.2.4 BIOTIME Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Elysium Health
2.3.1 Elysium Health Details
2.3.2 Elysium Health Major Business
2.3.3 Elysium Health Anti-Ageing Drugs Product and Services
2.3.4 Elysium Health Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 La Roche-Posay
2.4.1 La Roche-Posay Details
2.4.2 La Roche-Posay Major Business
2.4.3 La Roche-Posay Anti-Ageing Drugs Product and Services
2.4.4 La Roche-Posay Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 DermaFix
2.5.1 DermaFix Details
2.5.2 DermaFix Major Business
2.5.3 DermaFix Anti-Ageing Drugs Product and Services
2.5.4 DermaFix Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anti-Ageing Drugs Sales by Manufacturer
3.1 Global Anti-Ageing Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anti-Ageing Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anti-Ageing Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Ageing Drugs Manufacturer Market Share
3.4.2 Top 6 Anti-Ageing Drugs Manufacturer Market Share
3.5 Global Anti-Ageing Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anti-Ageing Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-Ageing Drugs Market Size by Region
4.1.1 Global Anti-Ageing Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Anti-Ageing Drugs Revenue by Region (2016-2026)
4.2 North America Anti-Ageing Drugs Revenue (2016-2026)
4.3 Europe Anti-Ageing Drugs Revenue (2016-2026)
4.4 Asia-Pacific Anti-Ageing Drugs Revenue (2016-2026)
4.5 South America Anti-Ageing Drugs Revenue (2016-2026)
4.6 Middle East and Africa Anti-Ageing Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anti-Ageing Drugs Sales in Volume by Type (2016-2026)
5.2 Global Anti-Ageing Drugs Revenue by Type (2016-2026)
5.3 Global Anti-Ageing Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anti-Ageing Drugs Sales in Volume by Application (2016-2026)
6.2 Global Anti-Ageing Drugs Revenue by Application (2016-2026)
6.3 Global Anti-Ageing Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anti-Ageing Drugs Sales by Type (2016-2026)
7.2 North America Anti-Ageing Drugs Sales by Application (2016-2026)
7.3 North America Anti-Ageing Drugs Market Size by Country
7.3.1 North America Anti-Ageing Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Anti-Ageing Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-Ageing Drugs Sales by Type (2016-2026)
8.2 Europe Anti-Ageing Drugs Sales by Application (2016-2026)
8.3 Europe Anti-Ageing Drugs Market Size by Country
8.3.1 Europe Anti-Ageing Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Anti-Ageing Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anti-Ageing Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Anti-Ageing Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Anti-Ageing Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-Ageing Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anti-Ageing Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anti-Ageing Drugs Sales by Type (2016-2026)
10.2 South America Anti-Ageing Drugs Sales by Application (2016-2026)
10.3 South America Anti-Ageing Drugs Market Size by Country
10.3.1 South America Anti-Ageing Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Anti-Ageing Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-Ageing Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Anti-Ageing Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Anti-Ageing Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-Ageing Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anti-Ageing Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anti-Ageing Drugs Typical Distributors
12.3 Anti-Ageing Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Anti-Ageing Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anti-Ageing Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Nu Skin Basic Information, Manufacturing Base and Competitors
Table 4. Nu Skin Major Business
Table 5. Nu Skin Anti-Ageing Drugs Product and Services
Table 6. Nu Skin Anti-Ageing Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. BIOTIME Basic Information, Manufacturing Base and Competitors
Table 8. BIOTIME Major Business
Table 9. BIOTIME Anti-Ageing Drugs Product and Services
Table 10. BIOTIME Anti-Ageing Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Elysium Health Basic Information, Manufacturing Base and Competitors
Table 12. Elysium Health Major Business
Table 13. Elysium Health Anti-Ageing Drugs Product and Services
Table 14. Elysium Health Anti-Ageing Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. La Roche-Posay Basic Information, Manufacturing Base and Competitors
Table 16. La Roche-Posay Major Business
Table 17. La Roche-Posay Anti-Ageing Drugs Product and Services
Table 18. La Roche-Posay Anti-Ageing Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. DermaFix Basic Information, Manufacturing Base and Competitors
Table 20. DermaFix Major Business
Table 21. DermaFix Anti-Ageing Drugs Product and Services
Table 22. DermaFix Anti-Ageing Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Anti-Ageing Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global Anti-Ageing Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Anti-Ageing Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Anti-Ageing Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Anti-Ageing Drugs Production Site of Key Manufacturer
Table 28. Global Anti-Ageing Drugs Sales by Region (2016-2021e) & (K Units)
Table 29. Global Anti-Ageing Drugs Sales by Region (2021-2026) & (K Units)
Table 30. Global Anti-Ageing Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Anti-Ageing Drugs Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Anti-Ageing Drugs Sales by Type (2016-2021e) & (K Units)
Table 33. Global Anti-Ageing Drugs Sales by Type (2021-2026) & (K Units)
Table 34. Global Anti-Ageing Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Anti-Ageing Drugs Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Anti-Ageing Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 37. Global Anti-Ageing Drugs Price by Type (2021-2026) & (USD/Unit)
Table 38. Global Anti-Ageing Drugs Sales by Application (2016-2021e) & (K Units)
Table 39. Global Anti-Ageing Drugs Sales by Application (2021-2026) & (K Units)
Table 40. Global Anti-Ageing Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Anti-Ageing Drugs Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Anti-Ageing Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 43. Global Anti-Ageing Drugs Price by Application (2021-2026) & (USD/Unit)
Table 44. North America Anti-Ageing Drugs Sales by Country (2016-2021e) & (K Units)
Table 45. North America Anti-Ageing Drugs Sales by Country (2021-2026) & (K Units)
Table 46. North America Anti-Ageing Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Anti-Ageing Drugs Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Anti-Ageing Drugs Sales by Type (2016-2021e) & (K Units)
Table 49. North America Anti-Ageing Drugs Sales by Type (2021-2026) & (K Units)
Table 50. North America Anti-Ageing Drugs Sales by Application (2016-2021e) & (K Units)
Table 51. North America Anti-Ageing Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Europe Anti-Ageing Drugs Sales by Country (2016-2021e) & (K Units)
Table 53. Europe Anti-Ageing Drugs Sales by Country (2021-2026) & (K Units)
Table 54. Europe Anti-Ageing Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Anti-Ageing Drugs Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Anti-Ageing Drugs Sales by Type (2016-2021e) & (K Units)
Table 57. Europe Anti-Ageing Drugs Sales by Type (2021-2026) & (K Units)
Table 58. Europe Anti-Ageing Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. Europe Anti-Ageing Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Asia-Pacific Anti-Ageing Drugs Sales by Region (2016-2021e) & (K Units)
Table 61. Asia-Pacific Anti-Ageing Drugs Sales by Region (2021-2026) & (K Units)
Table 62. Asia-Pacific Anti-Ageing Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Anti-Ageing Drugs Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Anti-Ageing Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Asia-Pacific Anti-Ageing Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Asia-Pacific Anti-Ageing Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. Asia-Pacific Anti-Ageing Drugs Sales by Application (2021-2026) & (K Units)
Table 68. South America Anti-Ageing Drugs Sales by Country (2016-2021e) & (K Units)
Table 69. South America Anti-Ageing Drugs Sales by Country (2021-2026) & (K Units)
Table 70. South America Anti-Ageing Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Anti-Ageing Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Anti-Ageing Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. South America Anti-Ageing Drugs Sales by Type (2021-2026) & (K Units)
Table 74. South America Anti-Ageing Drugs Sales by Application (2016-2021e) & (K Units)
Table 75. South America Anti-Ageing Drugs Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa Anti-Ageing Drugs Sales by Country (2016-2021e) & (K Units)
Table 77. Middle East & Africa Anti-Ageing Drugs Sales by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Anti-Ageing Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Anti-Ageing Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Anti-Ageing Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. Middle East & Africa Anti-Ageing Drugs Sales by Type (2021-2026) & (K Units)
Table 82. Middle East & Africa Anti-Ageing Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. Middle East & Africa Anti-Ageing Drugs Sales by Application (2021-2026) & (K Units)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Anti-Ageing Drugs Typical Distributors
Table 87. Anti-Ageing Drugs Typical Customers
List of Figures
Figure 1. Anti-Ageing Drugs Picture
Figure 2. Global Anti-Ageing Drugs Sales Market Share by Type in 2020
Figure 3. Hormonal Therapy
Figure 4. Antioxidants
Figure 5. Enzymes
Figure 6. Stem Cells
Figure 7. Others
Figure 8. Global Anti-Ageing Drugs Sales Market Share by Application in 2020
Figure 9. Skin
Figure 10. Hair
Figure 11. Others
Figure 12. Global Anti-Ageing Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Anti-Ageing Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Anti-Ageing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Anti-Ageing Drugs Sales (2016-2026) & (K Units)
Figure 34. Global Anti-Ageing Drugs Production Capacity (2016-2026) & (K Units)
Figure 35. Global Anti-Ageing Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Anti-Ageing Drugs Market Drivers
Figure 37. Anti-Ageing Drugs Market Restraints
Figure 38. Anti-Ageing Drugs Market Trends
Figure 39. Global Anti-Ageing Drugs Sales Market Share by Manufacturer in 2020
Figure 40. Global Anti-Ageing Drugs Revenue Market Share by Manufacturer in 2020
Figure 41. Anti-Ageing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Anti-Ageing Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Anti-Ageing Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Anti-Ageing Drugs Sales Market Share by Region (2016-2026)
Figure 45. Global Anti-Ageing Drugs Revenue Market Share by Region (2016-2026)
Figure 46. North America Anti-Ageing Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Europe Anti-Ageing Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Anti-Ageing Drugs Revenue (2016-2026) & (USD Million)
Figure 49. South America Anti-Ageing Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Anti-Ageing Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Global Anti-Ageing Drugs Sales Market Share by Type (2016-2026)
Figure 52. Global Anti-Ageing Drugs Revenue Market Share by Type (2016-2026)
Figure 53. Global Anti-Ageing Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Anti-Ageing Drugs Sales Market Share by Application (2016-2026)
Figure 55. Global Anti-Ageing Drugs Revenue Market Share by Application (2016-2026)
Figure 56. Global Anti-Ageing Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Anti-Ageing Drugs Sales Market Share by Country (2016-2026)
Figure 58. North America Anti-Ageing Drugs Revenue Market Share by Country (2016-2026)
Figure 59. North America Anti-Ageing Drugs Sales Market Share by Type (2016-2026)
Figure 60. North America Anti-Ageing Drugs Sales Market Share by Application (2016-2026)
Figure 61. Europe Anti-Ageing Drugs Sales Market Share by Country (2016-2026)
Figure 62. Europe Anti-Ageing Drugs Revenue Market Share by Country (2016-2026)
Figure 63. Europe Anti-Ageing Drugs Sales Market Share by Type (2016-2026)
Figure 64. Europe Anti-Ageing Drugs Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Anti-Ageing Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Anti-Ageing Drugs Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Anti-Ageing Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Anti-Ageing Drugs Sales Market Share by Application (2016-2026)
Figure 69. South America Anti-Ageing Drugs Sales Market Share by Country (2016-2026)
Figure 70. South America Anti-Ageing Drugs Revenue Market Share by Country (2016-2026)
Figure 71. South America Anti-Ageing Drugs Sales Market Share by Type (2016-2026)
Figure 72. South America Anti-Ageing Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Anti-Ageing Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Anti-Ageing Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Anti-Ageing Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Anti-Ageing Drugs Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[アンチエイジング薬の世界市場:ホルモン療法、抗酸化剤、酵素、幹細胞、その他] (Global Anti-Ageing Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR21AR00941)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆